Plumbers and Steamfitters Local 773 & PILMA-NY Tour

Posted: June 27, 2014

On June 27th, the Pharmaceutical Industry Labor-Management Association of NY (PILMA-NY) and Plumbers and Steamfitters Local 773 held a presentation and tour to showcase the partnership between the pharmaceutical industry and organized labor in New York. Click here to learn more.

0 comments

We Work for Health Pennsylvania Vendor Summit

Posted: May 16, 2014

GlaxoSmithKlein’s WWFH Pennsylvania Vendor Summit at GSK’s union-built Navy Yard facility in Philadelphia brought together Senator Pat Toomey (R-PA) and about 75 business leaders, policy makers and non-profit leaders to discuss the sector’s economic impact and opportunities for growth.

0 comments

PILMA Donates $125,000 to Helmets to Hardhats Program

Posted: November 15, 2013

The Pharmaceutical Industry Labor-Management Association (PILMA) presented Helmets to Hardhats with a check for $125,000 comprised of donations from pharmaceutical companies Eli Lilly, Johnson & Johnson, Merck, Novartis, and Pfizer during PILMA’s annual meeting on November 15.

0 comments

See all News >

Pharmaceutical Companies Among the Leaders in Keeping Construction Industry Humming

Posted on November 17, 2009July 15, 2014 by IronCore

Pharmaceutical Companies Among the Leaders in Keeping Construction Industry Humming

November 17, 2009

America’s Pharmaceutical companies are doing their share to keep the construction industry working as the U.S. emerges from recession. According to Engineering News Record, a McGraw-Hill publication that tracks construction spending, eight pharmaceutical companies have more than $1.3 billion worth of construction projects in the works.

That includes:

Johnson & Johnson $3,552 billion
Pfizer Inc. $1,804 billion
Wyeth $1,403.2 billion
Eli Lilly and Co. $1,098.3 billion
Schering-Plough $1,008 billion
Merck & Co. $871 billion
Amgen Inc. $826 billion

By comparison, Johnson & Johnson will spend more than three times the entire top 10 health services firms for construction in progress. Likewise, the top eight pharmaceutical companies in terms of construction are spending almost 40 percent more than the top 10 electronic firms; and 46 percent more than the top 10 communications firms.